Editorial: Decoding checkpoint inhibitor-induced endocrinopathies

Front Endocrinol (Lausanne). 2022 Jul 29:13:987648. doi: 10.3389/fendo.2022.987648. eCollection 2022.

Deborah L Burnett^{1

2}, Megan B Barnet^{1

2

3}, Katherine Samaras^{2

4

5}

¹ Immunology Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
² School of Clinical Medicine, St Vincent's Healthcare Clinical Campus, Faculty of Medicine and Health, University of New South Wales (UNSW), Sydney, NSW, Australia.
³ Department of Medical Oncology, St Vincent's Hospital, Darlinghurst, NSW, Australia.
⁴ Department of Endocrinology, St Vincent's Hospital, Darlinghurst, NSW, Australia.
⁵ Clinical Obesity, Nutrition, and Adipose Biology Lab, Clinical Science Pillar, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.

No abstract available

Keywords: autoimmune disease; cancer immunotherapies; endocrinopathies; immune checkpoint (ICP); irAE.

Publication types